• 検索結果がありません。

Ⅲ . 研究成果の刊行に関する一覧

N/A
N/A
Protected

Academic year: 2021

シェア "Ⅲ . 研究成果の刊行に関する一覧"

Copied!
5
0
0

読み込み中.... (全文を見る)

全文

(1)

       

Ⅲ. 研究成果の刊行に関する一覧

      

      書籍           

 著者氏名  論 文 タ イ ト ル

名 書籍全体の

 編集者名  書  籍  名 出版社名  出版地 出版年  ページ 大友耕太郎

岡本奈美, 門 野夕峰, 亀田 秀人, 川上 純, 岸本暢 将,小林茂人, 田村直人, 辻 成佳, 冨田哲 也, 中島康 晴, 中村好 一, 森雅亮, 森田明里, 山 村昌弘

分担執筆 冨 田 哲 也

,

田 村 直 人

,

門 野 夕 峰

,

亀 田 秀 人

,

小 林 茂 人

,

辻成佳

脊椎関節炎診

療の手引き 治 療 と 診

断社 東京

2020 1-147

田村直人

SLE

に対してシ クロホスファミ ド間欠静注療法 をどう行うか?

厚生労働科学 研究費補助金 難治性疾患等 政策研究事業  自己免疫疾患 に関する調査 研究(自己免 疫班)

 

全 身 性 エ リ テ マ ト ー デ ス 診 療 ガ イ ド ラ イ ン

南山堂 東京

2019 231-235

田村直人

SLE

に対してカ ルシニューリン 阻害薬をどう使 うか?

厚生労働科学 研究費補助金 難治性疾患等 政策研究事業  自己免疫疾患 に関する調査 研究(自己免 疫班)

 

全 身 性 エ リ テ マ ト ー デ ス 診 療 ガ イ ド ラ イ ン

南山堂 東京

2019 240-243

田村直人

SLE

に対してリ ツキシマブをど う使うか?

厚生労働科学 研究費補助金 難治性疾患等 政策研究事業  自己免疫疾患 に関する調査 研究(自己免 疫班)

 

全 身 性 エ リ テ マ ト ー デ ス 診 療 ガ イ ド ラ イ ン

南山堂 東京

2019 244-247

(2)

             雑誌 

発表者氏名 論文タイトル名 発表誌名 巻号 ページ 出版年

Dougados M, Wei JC, Landewé R, Sieper J, Baraliakos X, Van den Bosch F, Maksymowych WP, Ermann J, Walsh JA, Tomita T, Deodhar A, van der Heijde D, Li X, Zhao F, Bertram CC, Gallo G, Carlier H

 

Gensler LS COAST-V and COAST-W Study Groups. Efficacy and safety of ixekizumab through 52 weeks in two phase 3,

randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST- W).

 

Ann Rheum Dis. Epub ahead of print 2019

Kishimoto M, Yoshida K, Ichikawa N, Inoue H, Kaneko Y, Kawasaki T, Matsui K, Morita M, Suda M, Tada K, Takizawa N, Tamura N, Taniguchi A, Taniguchi Y, Tsuji S, Haji Y, Rokutanda R, Yanaoka H, Cheung PP, Gu J, Kim TH, Luo SF, Okada M, López Medina C, Molto A, Dougados M, Kobayashi S, van der Heijde D, Tomita T

 

Clinical characteristics of patients with

spondyloarthritis in japan in comparison with other regions of the world.

 

J Rheumatol 46(8)

 

896-903

 

2019

van der Hejide, Son g IH, Pangan A, De odhar A, Van den Bosch F, Maksymo wych WP, Kim TH, Kishimoto M, Everd ing A, Sui Y, Wang X, Chu AD, Sieper J

Efficacy and safety of upadacitinib in patient s with active ankylosin g spondylitis (SELECT -AXIS 1): a multicentr e, randomised, double- blind, placebo-controlle d, phase 2/3 trial.

Lancet 394 2108-2117 2019

(3)

Tam LS, Wei JC, Aggarwal A, Baek HJ, Cheung PP, Chiowchanwisawaki t P, Dans L, Gu J, Hagino N, Kishimoto M, Reyes HM, Soroosh S, Stebbings S, Whittle S, Yeap SS, Lau CS 

2018 APLAR axial spo ndyloarthritis treatme nt recommendations.

Int J Rheum Dis 22(3) 340-356 2019

Kishimoto M, Tanig uchi A, Fujishige A, Kaneko S, Haemm erle S, Porter BO, Kobayashi S

Efficacy and safety of secukinumab in Japan ese patients with activ e ankylosing spondyliti s: 24-week results fro m an open-label phase 3 study (MEASURE 2- J)

Mod Rheumatol online pub lished 2019

Kishimoto M, Yoshida K, Ichikawa N, Inoue H, Kaneko Y, Kawasaki T, Matsui K, Morita M, Suda M, Tada K, Takizawa N, Tamura N, Taniguchi A, Taniguchi Y, Tsuji S, Haji Y, Rokutanda R, Yanaoka H, Cheung PP, Gu J, Kim TH, Luo SF, Okada M, Medina CL, Molto A, Dougados M,

Kobayashi S, van der Heijde D, Tomita T 

Clinical characteristics of spondyloarthritis pa tients in Japan in com parison to other region s of the world.

J Rheumatol 46(8) 896-903 2019

Kawakami H, Naga oka Y, Hirano H, Matsumoto Y, Abe N, Tsuboi R, Kanno Y, Okubo Y

 

Evaluation of the effic acy of granulocyte and monocyte adsorption apheresis on skin man ifestation and joint sy mptoms of patients wi th pustulotic arthro-os teitis.

J Dermatol 46 144-148 2019

Masuda-Kuroki K, Murakami M, Kishibe M,

Kobayashi S, Okubo Y, Yamamoto T, Terui T, Sayama K.

Diagnostic histopatholo gical features distingui shing palmoplantar pu stulosis from pompholy x.

J Dermatol 46 399-408 2019

(4)

Tobita R, Egusa C, Maeda T, Abe N, S akai N, Suzuki S, Kawashima H, Hoki bara S, Ko J, Okub o Y

A novel CARD14 varia nt, homozygous c.526G

>C (p.Asp176His), in a n adolescent Japanese patient with palmoplan tar pustulosis.

Clin Exp Dermatol 44 694–696 2019

Terui T, Kobayashi S, Okubo Y, Murak ami M, Zheng R, M orishima H, Goto R, Kimura T.

Efficacy and Safety of Guselkumab in Japane se Patients With Palm oplantar Pustulosis: A Phase 3 Randomized C linical Trial.

JAMA Dermatol Epub ahea d of print 2019

Matsumoto Y, Hara da K, Maeda T, Eg usa C, Hirano H, O kubo Y, Tsuboi R

Molecular detection of fungal and bacterial D NA from pustules in p atients with palmoplan tar pustulosis: special focus on Malassezia sp ecies.

Clin Exp Dermatol Epub ahea d of print 2019

Kameda H, Fujii T, Nakajima A, Koike R, Sagawa A, Kanb e K, Tomita T, Har igai M, Suzuki Y

Japan College of Rheu matology subcommittee on the guideline for t he use of methotrexate in patients with rheu matoid arthritis.

Mod Rheumatol 29(1) 31-40 2019

Hara R, Umebayashi H, Takei S, Okamoto N, Iwata N,

Yamasaki Y,

Nakagishi Y, Kizawa T, Kobayashi I, Imagawa T, Kinjo N, Amano N, Takahashi Y, Mori M, Itoh Y, Yokota S

Intravenous abatacept in Japanese patients w ith polyarticular-course juvenile idiopathic art hritis: results from a p hase III open-label stu dy

Pediatr Rheumatol Online J 2019

Yasumura J, Yashiro M, Okamoto N, Shabana K, Umebayashi H, Iwata N, Okura Y, Kubota T, Shimizu M, Tomiita M, Nakagishi Y, Nishimura K, Hara R, Mizuta M, Yasumi T, Yamaide F, Wakiguchi H, Kobayashi M, Mori M

Clinical features and c haracteristics of uveitis associated with juveni le idiopathic arthritis i n Japan: first report o f the pediatric rheuma tology association of Ja pan (PRAJ)

Pediatr Rheumatol 17 15-24 2019

(5)

Okamoto N, Yokota

S, Takei S, et al Clinical practice guidance for juvenile idiopathic arthritis (JIA) 2018

Mod Rheumatol 29(1) 41-59 2019

Yasumura J, Yashiro M, Okamoto N, Shabana K, Umebayashi H, Iwata N, Okura Y, Kubota T, Shimizu M, Tomiita M, Nakagishi Y, Nishimura K, Hara R, Mizuta M, Yasumi T, Yamaide F, Wakiguchi H, Kobayashi M, Mori M

Clinical features and characteristics of uveitis associated with juvenile idiopathic arthritis in Japan: first report of the pediatric rheumatology

association of Japan (PRAJ)

Pediatr Rheumatol Online J 2019

Nakashima Y, Kond o M, Shono E, Ishi nishi T, Tsukamoto H, Kuroda K, Maey ama A, Harada H, Maekawa M, Shima uchi T, Nagamine R, Jojima H, Yoshiz awa S, Tsuru T, Ot suka T, Miyahara H, Suematsu E, Wa da K, Yoshizawa S, Inoue Y, Fukuda T, Ikemura S, Haragu chi A 

Suppression of joint de struction with subcuta neous tocilizumab for Japanese patients with rheumatoid arthritis i n clinical practice

Mod Rheumatol  Epub ahea d of print 2019

Fujikawa K, Kawas hiri SY, Endo Y, Mi zokami A, Tsukada T, Mine M, Uetani M, Kawakami A

Diagnostic efficacy of ultrasound detection of enthesitis in peripher al spondyloarthritis

Mod Rheum Epub

ahead of print

2019

Kawashiri SY, Fuji kawa K, Nishino A, Takatani A, Kawa kami A, Shimizu T, Umeda M, Fukui S, Igawa T, Koga T, Iwamoto N, Ichi nose K, Tamai M, Nakamura H, Orig uchi T, Mizokami A

Combination of ultraso und power Doppler-ver ified synovitis and ser opositivity accurately i dentifies patients with early rheumatoid arthr itis

Int J Rheum Dis 22(5) 842-851 2019

参照

関連したドキュメント

[Publications] Yamagishi, S., Yonekura.H., Yamamoto, Y., Katsuno, K., Sato, F., Mita, I., Ooka, H., Satozawa, N., Kawakami, T., Nomura, M.and Yamamoto, H.: "Advanced

Found in the diatomite of Tochibori Nigata, Ureshino Saga, Hirazawa Miyagi, Kanou and Ooike Nagano, and in the mudstone of NakamuraIrizawa Yamanashi, Kawabe Nagano.. cal with

[Publications] Taniguchi, K., Yonemura, Y., Nojima, N., Hirono, Y., Fushida, S., Fujimura, T., Miwa, K., Endo, Y., Yamamoto, H., Watanabe, H.: "The relation between the

Araki, Y., Tang, N., Ohno, M., Kameda, T., Toriba, A., Hayakawa, K.: Analysis of atmospheric polycyclic aromatic hydrocarbons and nitropolycyclic aromatic hydrocarbons

If k is larger than n, the dimension of M , then B k (M) is equiva- lent to the normal homotopy type of M : Two manifolds have the same (= fibre homotopy equivalent) normal k-type

(4) Roughly speaking, the C 1 smooth submanifolds M are expected to produce much larger tangencies (with respect to D) than those produced by C 2 smooth submanifolds.. Analogously,

Nagy-Foias (N-F) respectivamente, los de Nehari y Paley, los teoremas de parametrización y de aproximación de A-A-K y el teorema de extensión de Krein. Más aún, los NTGs conducen

In this lecture, we aim at presenting a certain linear operator which is defined by means of the Hadamard product (or convolu- tion) with a generalized hypergeometric function and